# Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis

> **NCT01452698** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 409 (actual)

## Conditions studied

- Erosive Esophagitis

## Interventions

- **DRUG:** TAK-438
- **DRUG:** Placebo
- **DRUG:** Lansoprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01452698
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 409 (ACTUAL)
- **Last updated:** 2012-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01452698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01452698, "Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01452698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*